Real-world Data Leadership Graticule positions itself as a real-world data network operator focused on evidence generation and access to US and international data sources. This suggests a strong sales opportunity in selling RWD access, data partnerships, and consulting services to life sciences companies seeking real-world evidence for market access and post-market studies.

Health System Network The company emphasizes a growing health system partner network to enable longitudinal patient journey data. This indicates potential upsell of expanded data access, larger-scale studies, and value-added services around study planning, data standardization, and regulatory-ready datasets.

Regulatory Ready Graticule highlights use in regulatory and payer contexts for safety, effectiveness, and value questions. This presents opportunities in supporting health technology assessments, payer evidence dossiers, and submissions for market access in both US and EU markets.

Strategic Alliances Key personnel changes and partnerships (EU Chief Alliance Officer, US Director of BD, Deep 6 collaboration) signal a growth-oriented sales motion with alliances. Target opportunities could include co-sell arrangements, partner-led go-to-market, and cross-sell of data services through ecosystem partners.

Growth Signals Award finalist recognition for innovation and a revenue range in the low millions indicate traction and credibility. Use these signals to approach prospects with validated capabilities, emphasize scalability of the RWD network, and propose phased pilot projects to de-risk adoption.